Pictilisib

DB11663InvestigationalSmall molecule

Pictilisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Advanced Solid Tumours, Metastatic Breast Cancer, and Non-Hodgkin's Lymphoma, Solid Cancers, among others.

Formula / weight: C₂₃H₂₇N₇O₃S₂ · 513.636 g/mol (avg)
Code names: GDC-0941

Resolves to

Compound

UNIIICY00EMP8PCAS957054-30-7ChEMBLCHEMBL521851ChEBI65326PubChem17755052

Structure

InChIKeyLHNIIDJUOCFXAP-UHFFFAOYSA-NSMILESCS(=O)(=O)N1CCN(CC2=CC3=C(S2)C(=NC(=N3)C2=C3C=NNC3=CC=C2)N2CCOCC2)CC1

Targets

P48736PIK3CG

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

13Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pictilisib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account